IGHID 12230 - An Implementation Trial of an Experiential Brief Alcohol Intervention for HIV Prevention
EBAI
IGHID 12230 - Scaling up the Brief Alcohol Intervention to Prevent HIV Infection in Vietnam: a Cluster Randomized, Implementation Trial (EBAI)
2 other identifiers
interventional
3,234
1 country
1
Brief Summary
This study is a hybrid type 3, cluster randomized implementation trial to examine effective strategies to scale up the Brief Alcohol Intervention (BAI) in ART clinics in Vietnam. One arm will receive only facilitation for BAI implementation. Facilitation is a flexible strategy that helps clinics to address common barriers, such as counselor skills, competing priorities, and resource deficits. In the other arm, in addition to facilitation, clinic staff, irrespective of their own alcohol use, will be offered the BAI themselves as experiential learning (EBAI) to address their own alcohol-related attitudes and behaviors. Clinic staff responsible for delivering the BAI to patients will also be offered 3 consolidation activities to integrate their own experiences with their delivery of the BAI.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 1, 2024
CompletedFirst Posted
Study publicly available on registry
April 11, 2024
CompletedStudy Start
First participant enrolled
April 25, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 1, 2026
December 30, 2025
June 1, 2025
2.5 years
April 1, 2024
December 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Fidelity Score
Fidelity is a clinic-level measure assessed as a composite of the recipients of the BAI. The timeframe of 15 months reflects individual recruitment over 12 months plus 3 months for completion of the BAI. The score comprises successful completion of the 4 protocol-specified BAI sessions (2 in-person, 2 by phone) within 7 weeks of the initial session weighted by the central fidelity rater's quality rating of the in-person sessions. Fidelity will be assessed using a tailored selection of fidelity measures including the BAI Core Components Checklist. The clinic fidelity score ranges from 0-100. The score will be the percentage of counseling sessions completed, multiplied (weighted) by the combined average quality rating of counseling sessions. Higher scores indicate higher fidelity.
15 months
Viral Suppression
Viral suppression is defined as a viral load \<1000 copies/mL on a dried blood spot (DBS) sample collected 12 months after enrollment of a participant.
12 months
Secondary Outcomes (10)
BAI Acceptability Score - Clinic Staff: Acceptability of Intervention Measure (AIM) scale
Up to 12 months
BAI Acceptability score Counselors: Mental Health Implementation Science Tools (mhIST) Acceptability Scale for Providers
Up to 12 months
BAI Acceptability PWH: Mental Health Implementation Science Tools (mhIST) Acceptability Scale for Consumers
Up to 12 months
Penetration- Proportion of PWH Screened with the AUDIT-C
Up to 12 months
Penetration - Proportion of PWH who screen positive who receive at least one counseling session
Up to 12 months
- +5 more secondary outcomes
Study Arms (2)
Facilitation Only (FAC)
ACTIVE COMPARATORClinics randomized to the FAC arm will implement BAI delivery to PWH using the facilitation only approach.
Facilitation Plus an Experiential Brief Alcohol Intervention (EBAI+FAC)
EXPERIMENTALClinics randomized to the EBAI+FAC arm will implement BAI delivery to PWH participants using the facilitation approach. Additionally, clinic staff, irrespective of their own alcohol use, will be offered the BAI themselves prior to delivering the BAI.
Interventions
The facilitation approach will use a flexible clinic level implementation strategy that helps clinics to address common barriers, such as counselor skills, competing priorities, and resource deficits.
Clinic staff will be offered the experiential BAI prior to implementation. The BAI comprises 2 in-person sessions and 2 booster phone sessions. Clinic staff responsible for delivering the BAI to PWH participants will be offered 3 additional consolidation sessions to integrate their experiences receiving the BAI with their delivery of the BAI.
Eligibility Criteria
You may qualify if:
- PWH cohort participants
- Person living with HIV at any stage of HIV infection
- Currently attending the study ART clinic at any ART stage (initiating or receiving ART)
- AUDIT-C score \>=4 for men or \>=3 for women
- \>= 18 years of age
- Willing to provide informed consent, which includes consenting to interview and collection of dried blood spots
- Clinic staff participants:
- Work at the ART clinic as a clinic director, physician, nurse, or counselor
- Willing to provide informed consent
You may not qualify if:
- PWH cohort participants:
- Psychological disturbance preventing participation
- Cognitive impairment
- Threatening behavior
- Unwilling to provide locator information Note: If a participant screens positive with the AUDIT-C and is identified to be at substantial risk for alcohol withdrawal based on the Mini International Neuropsychiatric Interview (MINI) and Clinical Institute Withdrawal Assessment of Alcohol Scale (CIWA) will be referred for treatment. They will not be eligible for enrollment until after alcohol withdrawal concerns are addressed.
- These participants may be rescreened, consented, and enrolled after treatment.
- Clinic staff participants:
- Psychological disturbance, cognitive impairment, or threatening behavior
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Washingtoncollaborator
- Washington University School of Medicinecollaborator
- University of North Carolina, Chapel Hilllead
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)collaborator
- National Institutes of Health (NIH)collaborator
- Hanoi Medical Universitycollaborator
- Johns Hopkins Universitycollaborator
Study Sites (1)
Hanoi Medical University
Hanoi, Vietnam
Related Publications (1)
Bartels SM, Phan HTT, Hutton HE, Nhan DT, Sripaipan T, Chen JS, Rossi SL, Ferguson O, Nong HTT, Nguyen NTK, Giang LM, Bui HTM, Chander G, Sohn H, Kim S, Tran HV, Nguyen MX, Powell BJ, Pence BW, Miller WC, Go VF. Scaling up a brief alcohol intervention to prevent HIV infection in Vietnam: a cluster randomized, implementation trial. Implement Sci. 2024 Jun 12;19(1):40. doi: 10.1186/s13012-024-01368-6.
PMID: 38867283DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Vivian Go, MD
University of North Carolina
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 1, 2024
First Posted
April 11, 2024
Study Start
April 25, 2024
Primary Completion (Estimated)
November 1, 2026
Study Completion (Estimated)
November 1, 2026
Last Updated
December 30, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- beginning 9 and continuing for 36 months following publication
- Access Criteria
- Investigator who proposes to use the data has approved IRB, IEC, or REB and an executed data use/sharing agreement with UNC.
Deidentified individual data that supports the results will be shared beginning 9 to 36 months following publication provided the investigator who proposes to use the data has approval from an Institutional Review Board (IRB), Independent Ethics Committee (IEC), or Research Ethics Board (REB), as applicable, and executes a data use/sharing agreement with UNC.